Telehealth & Clinics

Clinical-grade safety content — without the clinical writing overhead.

Your patients are combining GLP-1 medications, cannabis, and complex drug regimens. Pharmacist-reviewed, citation-ready content from InteractSafe gives your team a credible foundation for patient guidance.

Clinical Pain Points

The questions your providers are already fielding.

"My patient is on Wegovy and using cannabis to manage appetite. What should I tell them?"
"We need a patient handout on cannabis + warfarin but don't have a pharmacist on staff."
"Our portal needs a resource page on drug interactions — can you point me to something defensible?"

Providers lack time to draft and maintain safety content. Linking to consumer health websites carries reputational and accuracy risk. Building in-house requires pharmacist time you may not have.

What InteractSafe Provides

Pharmacist-reviewed content, ready to deploy.

  • Cannabis + GLP-1 interaction guides (semaglutide, tirzepatide, dulaglutide)
  • Cannabis + blood thinners (warfarin, apixaban, rivaroxaban)
  • Cannabis + antidepressant and psychiatric medication guides
  • Edibles and delayed gastric emptying — particularly relevant for GLP-1 patients
  • White-label or co-branded formatting available
  • All content reviewed by Sanford A. Orloff, RPh (ret), NPI 1518289974
  • Sources: FDA, NIH, PubMed — no commercial health website content
Integration Options

How clinics and telehealth providers work with us

🖥️

Patient Portal Content

Embed the checker or link to specific pharmacist-reviewed guides from your patient portal — a trusted resource for patients reviewing their medications before or after appointments.

Widget details →
📋

Provider Reference Pages

Use licensed content as an internal reference layer for clinical staff — a quick, reliable summary of cannabis and GLP-1 interactions they can pull up during appointments.

Licensing options →
🗂️

Patient Onboarding Materials

Include pharmacist-reviewed interaction summaries in new patient onboarding — particularly for GLP-1 prescribers whose patients may be asking about cannabis use.

Education tools →
🔬

Cannabis Clinic Intake

For cannabis-specific clinics, embed the checker as part of intake — patients see their medication risks before they consult with a provider, making the conversation more productive.

Widget details →
🏷️

Co-Branded or White-Label

Licensed content can be delivered with your branding or as plain white-label HTML. Ask about co-branding options for patient-facing materials at the demo stage.

Contact us →
🔄

Content Maintenance

InteractSafe guides are updated as new research emerges and drug labeling changes. Licensed content includes update notifications — you're not buying a static document.

How licensing works →
Compliance

What your compliance team will ask — answered.

Is this HIPAA-compliant?

InteractSafe is not a covered entity and does not store or transmit PHI. The checker is anonymous and session-based. No patient data flows to us. Full details →

Is this considered medical advice?

No. All content is clearly framed as educational reference material, not clinical guidance. Patients are directed to consult their prescriber. Disclaimer language is included in all deliverables.

Who reviewed this content?

Sanford A. Orloff, RPh (ret), NPI 1518289974 — 40+ years clinical pharmacy experience. All sources are traced to FDA, NIH, and peer-reviewed literature.

Can we verify the sources?

Yes. Every guide includes source citations with direct links to FDA labels, NIH publications, and PubMed abstracts. Nothing is sourced from commercial health websites.

Ideal for
  • GLP-1 telehealth prescribers (Ro, Hims, Noom Med, etc.)
  • Cannabis-specific medical clinics
  • Primary care groups with high GLP-1 patient volume
  • Integrative medicine and functional medicine practices
  • Health system patient education departments
  • Digital health apps with medication management features
Talk to Partners About Clinical Integration

Bring pharmacist-reviewed content to your clinical platform.

We work with telehealth providers, cannabis clinics, and health systems. Tell us about your setup and patient population.